Samsung BioLogics wins potential $148m contract at new plant
The manufacturing contract is the first of what Samsung BioLogics expects to be a number of long-term partnerships at its recently completed 180,000L facility.
Archives for February 23, 2018
Perfusion to fed-batch: Repligen record quarter for ATF tech
Repligen says the single-use version of its alternating tangential flow (ATF) platform is helping the firm capture a larger share of the fed-batch bioreactor marketplace.